Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
BMC Cancer ; 10: 367, 2010 Jul 12.
Article in English | MEDLINE | ID: mdl-20618998

ABSTRACT

BACKGROUND: MicroRNAs (miRNAs) can function as either oncogenes or tumor suppressor genes via regulation of cell proliferation and/or apoptosis. MiR-221 and miR-222 were discovered to induce cell growth and cell cycle progression via direct targeting of p27 and p57 in various human malignancies. However, the roles of miR-221 and miR-222 have not been reported in human gastric cancer. In this study, we examined the impact of miR-221 and miR-222 on human gastric cancer cells, and identified target genes for miR-221 and miR-222 that might mediate their biology. METHODS: The human gastric cancer cell line SGC7901 was transfected with AS-miR-221/222 or transduced with pMSCV-miR-221/222 to knockdown or restore expression of miR-221 and miR-222, respectively. The effects of miR-221 and miR-222 were then assessed by cell viability, cell cycle analysis, apoptosis, transwell, and clonogenic assay. Potential target genes were identified by Western blot and luciferase reporter assay. RESULTS: Upregulation of miR-221 and miR-222 induced the malignant phenotype of SGC7901 cells, whereas knockdown of miR-221 and miR-222 reversed this phenotype via induction of PTEN expression. In addition, knockdonwn of miR-221 and miR-222 inhibited cell growth and invasion and increased the radiosensitivity of SGC7901 cells. Notably, the seed sequence of miR-221 and miR-222 matched the 3'UTR of PTEN, and introducing a PTEN cDNA without the 3'UTR into SGC7901 cells abrogated the miR-221 and miR-222-induced malignant phenotype. PTEN-3'UTR luciferase reporter assay confirmed PTEN as a direct target of miR-221 and miR-222. CONCLUSION: These results demonstrate that miR-221 and miR-222 regulate radiosensitivity, and cell growth and invasion of SGC7901 cells, possibly via direct modulation of PTEN expression. Our study suggests that inhibition of miR-221 and miR-222 might form a novel therapeutic strategy for human gastric cancer.


Subject(s)
Cell Proliferation , Gene Expression Regulation, Neoplastic , MicroRNAs/physiology , PTEN Phosphohydrolase/metabolism , Radiation Tolerance/genetics , Stomach Neoplasms/pathology , Animals , Apoptosis , Blotting, Northern , Blotting, Western , Cell Adhesion , Cell Cycle , Cell Movement , Cells, Cultured , Fibroblasts/cytology , Fibroblasts/metabolism , Gamma Rays , Humans , Immunoenzyme Techniques , Kidney/cytology , Kidney/metabolism , Mice , NIH 3T3 Cells , PTEN Phosphohydrolase/antagonists & inhibitors , PTEN Phosphohydrolase/genetics , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Stomach Neoplasms/genetics , Stomach Neoplasms/radiotherapy
2.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-349070

ABSTRACT

<p><b>OBJECTIVE</b>To construct a recombinant adenovirus vector that expresses small hairpin RNAs (shRNA) against COX-2, AKT1 and PIK3R1 gene and to evaluate its potential for suppressing the cell proliferation of human gastric adenocarcinoma SGC701 cell in vitro and in vivo, which will enable the development of a gene therapy protocol for the treatment of human gastric adenocarcinoma.</p><p><b>METHODS</b>Three strips of shRNA targeting AKT1, COX-2 and PIK3R1, was subcloned into adenovirus expression vector. After verification, it was amplified and titered. The recombinant adenovirus expression vector was infected into human gastric adenocarcinoma SGC7901 cells in vitro and the infected cells were injected in nude mice. The mRNA and protein expression levels of AKT1, COX-2 and PIK3R1 were determined by real-time PCR and Western blot respectively. Cell proliferation in vitro was determined by methyl thiazolyltetrazolium (MTT) assay and flow cytometry, tumor growth in vivo was measured by volume of tumor in nude mice.</p><p><b>RESULTS</b>Restriction digestion and sequencing analysis showed that the rAd5-C-A-P adenovirus expression vector was constructed successfully. It significantly inhibited the expression of AKT1, COX-2 and PIK3R1, and cell growth was inhibited over 70% as indicated by MTT assay and accompanied with G0/G1 phase arrest. Cell growth on matrigel matrix showed that the rAd5-C-A-P transfected cells were detached from the matrix or grew in a scattered clustering pattern, indicating poor cell growth activities in 2-D matrigel. Tumor growth in nude mice in the C + A + P group was inhibited (P<0.01).</p><p><b>CONCLUSION</b>shRNA targeting COX-2, AKT1 and PIK3R1 down regulated significantly the expression of the three genes in a sequence-specific manner, exerted proliferation inhibition effect on SGC7901 cells in vitro and in vivo.</p>


Subject(s)
Animals , Humans , Mice , Adenocarcinoma , Genetics , Therapeutics , Adenoviridae , Genetics , Metabolism , Cell Line, Tumor , Cell Proliferation , Cyclooxygenase 2 , Genetics , Metabolism , Disease Models, Animal , Down-Regulation , Genetic Therapy , Genetic Vectors , Genetics , Metabolism , Inverted Repeat Sequences , Mice, Nude , Phosphatidylinositol 3-Kinases , Genetics , Proto-Oncogene Proteins c-akt , Genetics , Metabolism , RNA Interference , RNA, Small Interfering , Genetics , Therapeutic Uses , Stomach Neoplasms , Genetics , Therapeutics
SELECTION OF CITATIONS
SEARCH DETAIL
...